{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:04:05Z","timestamp":1771315445112,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>Comparisons of SARS\u2010CoV\u20102 variants' severity in terms of outcomes such as hospitalisation are commonly reported. By contrast, despite the vital importance of understanding evolution of the SARS\u2010CoV\u20102 symptom profile for public health surveillance, few comparative studies have investigated differences in variants' symptomatology. The aim of this comprehensive analysis was to investigate whether successive variants were indeed associated with distinct symptom patterns in a large Welsh sample covering a broad time period and multiple variant waves. Symptom and variant typing data were derived from contact tracing data and sequencing of positive SARS\u2010CoV\u20102 PCR tests collected in Wales, respectively. Descriptive epidemiology and binary logistic regression modelling were then used to investigate differences in the symptom profile of N\u2009=\u2009226\u2009002 cases infected with Wild\u2010Type, Alpha, Delta, or Omicron variants of SARS\u2010CoV\u20102. The median number of symptoms and the proportion of cases reporting as symptomatic were lower for those infected with Omicron (BA.4) and Omicron (BA.5) compared to those infected with Wild\u2010Type (B.1.612), Alpha (B.1.1.7), Delta (B.1.617.2 and descendent lineages, excluding AY.4.2), Delta (AY.4.2), Omicron (BA.1) and Omicron (BA.2). Indeed, the odds of being symptomatic when infected with the Omicron (BA.4) or Omicron (BA.5) variant were 83% and 84% lower, compared to those infected with Wild\u2010Type. Anosmia in particular, was reported in non\u2010Omicron variants at approximately three\u2010to\u2010five times the proportion of cases (range 20.23%\u201326.41%) compared to Omicron variants (range 4.18%\u20137.65%). Indeed, the odds of having anosmia when infected with an Omicron variant were 85%\u201391% lower than when infected with Wild\u2010Type, versus 32%\u201343% lower for non\u2010Omicron variants, relative to Wild\u2010Type. We suggest, given these changes in symptomatology and the vast reduction in testing and sequencing, symptom surveillance should continue, to approximate burden of infection and facilitate rapid updating of clinical case definitions following any further evolution in the symptom profile. While disentangling the contribution of genomic, immunological and sampling changes to our findings remains challenging, symptom surveillance could also potentially aid emerging variant detection when used in combination with other surveillance approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jmv.70717","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T10:56:23Z","timestamp":1765191383000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Variance in the Variants: A Comparison of the Symptomatology of SARS\u2010CoV\u20102 Variants in Wales, February 2020\u2013July 2022"],"prefix":"10.1002","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1654-7780","authenticated-orcid":false,"given":"Felicity","family":"Simkin","sequence":"first","affiliation":[{"name":"Communicable Disease Surveillance Centre (CDSC), Public Health Wales Cardiff Wales UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Postans","sequence":"additional","affiliation":[{"name":"Communicable Disease Surveillance Centre (CDSC), Public Health Wales Cardiff Wales UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Pacchiarini","sequence":"additional","affiliation":[{"name":"Communicable Disease Surveillance Centre (CDSC), Public Health Wales Cardiff Wales UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Song","sequence":"additional","affiliation":[{"name":"Communicable Disease Surveillance Centre (CDSC), Public Health Wales Cardiff Wales UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Cottrell","sequence":"additional","affiliation":[{"name":"Communicable Disease Surveillance Centre (CDSC), Public Health Wales Cardiff Wales UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-0930","authenticated-orcid":false,"given":"Catherine","family":"Moore","sequence":"additional","affiliation":[{"name":"Wales Specialist Virology Centre, Microbiology, Public Health Wales Cardiff Wales UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Connor","sequence":"additional","affiliation":[{"name":"Pathogen Genomics Unit, Public Health Wales Cardiff Wales UK"},{"name":"Cardiff University School of Biosciences Cardiff University Cardiff Wales UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Williams","sequence":"additional","affiliation":[{"name":"Communicable Disease Surveillance Centre (CDSC), Public Health Wales Cardiff Wales UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"GOV.UK Wales Confirms First Positive Case of Coronavirus (COVID\u201019) | GOV.WALES 2020c https:\/\/www.gov.wales\/wales-confirms-first-positive-case-coronavirus-covid-19."},{"key":"e_1_2_10_3_1","unstructured":"GOV.UK Prime Minister's Statement on Coronavirus (COVID\u201019): 12 March 2020 \u2010 GOV.UK 2020a https:\/\/www.gov.uk\/government\/speeches\/pm-statement-on-coronavirus-12-march-2020."},{"key":"e_1_2_10_4_1","unstructured":"GOV.UK Statement From the UK Chief Medical Officers on an Update to Coronavirus Symptoms: 18 May 2020 \u2010 GOV.UK 2020b https:\/\/www.gov.uk\/government\/news\/statement-from-the-uk-chief-medical-officers-on-an-update-to-coronavirus-symptoms-18-may-2020."},{"key":"e_1_2_10_5_1","unstructured":"GOV.UK People With Symptoms of a Respiratory Infection Including COVID\u201019 \u2010 GOV.UK 2022b https:\/\/www.gov.uk\/guidance\/people-with-symptoms-of-a-respiratory-infection-including-covid-19#full-publication-update-history."},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34244-2"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMANETWORKOPEN.2021.37257"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIAA855"},{"key":"e_1_2_10_9_1","unstructured":"GOV.UK Changes to Testing and Care Homes as We All Learn to Live Safely With Coronavirus | GOV.WALES 2022a https:\/\/www.gov.wales\/changes-testing-and-care-homes-we-all-learn-live-safely-coronavirus."},{"key":"e_1_2_10_10_1","unstructured":"BBC Coronavirus: Drive\u2010Through Testing Centre Launched in Wales \u2010 BBC News 2020 https:\/\/www.bbc.co.uk\/news\/uk-wales-51766298."},{"key":"e_1_2_10_11_1","unstructured":"Welsh Parliament Coronavirus Timeline: The Response in Wales 2023 https:\/\/research.senedd.wales\/research-articles\/coronavirus-timeline-the-response-in-wales\/."},{"key":"e_1_2_10_12_1","unstructured":"R Companion 3E 2019 https:\/\/www.john-fox.ca\/Companion\/index.html."},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMANETWORKOPEN.2023.2328"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/OFID\/OFAD275"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPUBH.2023.1149795"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/JMV.28066"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JINF.2021.07.008"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/IRV.13021"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.N288"},{"key":"e_1_2_10_20_1","unstructured":"NHS England. (n.d.). Statistics\u202f\u00bb COVID\u201019 Therapeutics (Antivirals Neutralising Monoclonal Antibodies and Interleukin 6 Inhibitors). Retrieved April 8 2025 fromhttps:\/\/www.england.nhs.uk\/statistics\/statistical-work-areas\/covid-therapeutics-antivirals-and-neutralising-monoclonal-antibodies\/."},{"key":"e_1_2_10_21_1","unstructured":"Public Health Wales 2023 Sero\u2010Surveillance of SARS\u2010CoV\u20102 in Welsh Blood Donors."},{"key":"e_1_2_10_22_1","unstructured":"UKHSA2022 SARS\u2010CoV\u20102 Variants of Concern and Variants Under Investigation in England."},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00462-7"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIAC921"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJGH-2023-012328"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00327-0"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.70717","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jmv.70717","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.70717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T07:11:27Z","timestamp":1771312287000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.70717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1002\/jmv.70717"],"URL":"https:\/\/doi.org\/10.1002\/jmv.70717","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2025-04-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70717"}}